SIGN UP
LOG IN
A
ALNY
Alnylam Pharmaceuticals Inc
289.96
0.96+0.33%After Hours: 289.96 0.00 0.00%16:29 05/23 EDT
OPEN/PREV CLOSE286.39/289.00
TODAY RANGE284.19-291.22
VOL757.02K
MARKET CAP37.81B
52 WEEK RANGE146.79-304.39
AVG VOL (3M)996.54K
% TURNOVER0.58%
TURNOVER--
P/E (TTM)-138.5446
% RANGE2.43%
EPS(TTM)-2.0929
P/E(FORWARD)-213.9926
P/B327.34
BVPS0.8858
DIVIDEND--
P/S16.68
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP36.26B
SHARES OUTSTANDING130.39M
NEXT EARNINGS07/30-08/04
FREE FLOAT125.05M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·2d ago
The Play On BridgeBio Pharma: Great Expectations For Attruby
TipRanks·4d ago
TD Cowen Reaffirms Their Buy Rating on Alnylam Pharma (ALNY)
Seeking Alpha·5d ago
Why I Moved On From BMEZ Despite A 14.2% Yield (Rating Downgrade)
Seeking Alpha·6d ago
Alnylam posts new Phase 3 data for heart disease therapy Amvuttra
Reuters·05/15 07:41
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, UnitedHealth, Wells Fargo
TipRanks·05/13 21:29
Alnylam Pharma Re-elects Directors at Annual Meeting
TipRanks·05/13 02:01
Director Makes Strategic Move with Alnylam Pharma Stock Purchase
Simply Wall St·05/12 17:20
Alnylam Pharmaceuticals (NasdaqGS:ALNY) To Present Pivotal TTR Franchise Data At Heart Failure Congress
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.